Should I Buy CHRW? CHRW 2026 Analysis

Should You Buy CH Robinson Worldwide Inc (CHRW) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Hold

Latest Price

200.590

1 Day change

1.60%

52 Week Range

203.340

Analysis Updated At

2026/02/04

Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Not a good buy right now: price is extended after earnings, with momentum very overbought and sitting near the next resistance zone.
If you must act immediately, the odds favor chasing risk (pullback first) rather than an attractive fresh entry at current pre-market levels (~201).
Bullish medium-term setup remains intact (trend + analyst upgrades + operational productivity narrative), but the near-term entry is poor given the technical stretch.

Technical Analysis

Trend: Bullish structure with SMA_5 > SMA_20 > SMA_200, confirming an uptrend.
Momentum: MACD histogram +2.062 and expanding supports continued bullish momentum.
Overbought: RSI_6 = 93.7 is extremely overbought, often followed by consolidation/pullback.
Levels: Pivot 188.2 (key near-term support area). Resistance: R1 198.65 (already reclaimed) and R2 205.11 (next upside ceiling). Pre-market ~201 is in the upper resistance band, not near support.
Pattern-based outlook: Similar-pattern stats imply modest 1-day downside risk (-0.73%) but positive 1-week/1-month drift (+3.6% / +8.38%), reinforcing “bullish trend but stretched entry.”

Options Data

Bullish

Open Interest Put-Call Ratio

Bullish

Option Volume Put-Call Ratio

Sentiment: Put/call ratios are very call-heavy (OI PCR 0.34; Volume PCR 0.11) → bullish/optimistic positioning.
Activity: Today’s option volume 5,968 vs 30-day avg is ~313%, showing a strong post-event surge in participation.
Volatility: IV 30d 34.31 vs HV 57.81 (IV below realized) with IV percentile ~51.6 → options not extremely “priced for panic,” consistent with constructive sentiment.
Interpretation: Options flows look supportive, but call-heaviness after an earnings gap can also coincide with near-term crowding (less favorable for immediate entry).

Technical Summary

Sell

Buy

Positive Catalysts

- Earnings beat narrative: Q4 adjusted EPS $1.23 (+1.7% YoY) and beat expectations despite weak freight.
- Operational leverage/productivity: Multiple analysts highlighted lean, tech-enabled model and personnel cost discipline.
- Share gains: Commentary points to continued market share gains (including truckload volume growth and ongoing NAST share gains).
- Street support: Broad-based price target raises and many reiterated Buys/Outperforms post-print.

Neutral/Negative Catalysts

- Fundamental top-line pressure: Q4 revenue -6.5% YoY and net profit down, showing cycle headwinds remain.
- Near-term technical risk: Extreme overbought RSI + trading near resistance (around 205).
- Skeptical bear case exists: Morgan Stanley remains Underweight and questions sustainability/uniqueness of AI/productivity benefits.
- Positioning risk: Very bullish options skew can increase vulnerability to a “sell-the-news” or digestion move.

Financial Performance

Latest quarter: 2025/Q4.
Revenue: $3.912B, -6.5% YoY (continued freight-cycle pressure).
Net income: $136.3M, -8.7% YoY.
EPS: $1.12, -8.2% YoY (GAAP), while adjusted profitability narrative was stronger.
Margin: Gross margin 16.79%, +2.63% YoY → efficiency/productivity improvements partially offset demand weakness.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Recent trend: Strong wave of price target increases after Q4 results.
Bullish/pro view: Susquehanna (Positive, $220), Baird (Outperform, $203), Evercore (Outperform, $219), Stifel (Buy, $202), BofA (Buy, $225), Deutsche Bank (Buy, $200), Truist (Buy, $210) cite share gains, productivity, and cost structure improvements.
Neutral/mixed: Citi (Neutral, $202), BMO (Market Perform, $180) acknowledge execution but remain balanced on cycle.
Bearish outlier: Morgan Stanley (Underweight, $90) highlights cycle pressures and wants clearer proof of sustainable AI-driven advantage.
Net takeaway: Wall Street is broadly constructive on execution and operating leverage, but the stock’s current stretched technicals make “buy right now” unattractive despite improving sentiment.

20 Analyst Rating

Wall Street analysts forecast CHRW stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for CHRW is 167.65 USD with a low forecast of 85 USD and a high forecast of 210 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

14 Buy

5 Hold

1 Sell

Moderate Buy

Current: 197.440

Low

Averages

167.65

High

210

Current: 197.440

Low

Averages

167.65

High

210

Citi

Neutral

maintain

$177 -> $202

AI Analysis

2026-01-30

Reason

Citi

Price Target

$177 -> $202

AI Analysis

2026-01-30

maintain

Neutral

Reason

Citi raised the firm's price target on C.H. Robinson to $202 from $177 and keeps a Neutral rating on the shares.

Susquehanna

Positive

maintain

$210 -> $220

2026-01-29

Reason

Susquehanna

Price Target

$210 -> $220

2026-01-29

maintain

Positive

Reason

Susquehanna raised the firm's price target on C.H. Robinson to $220 from $210 and keeps a Positive rating on the shares. The firm said the company ended 4Q and started 1Q under pressure, but management guided personnel expense down in 2026, and messaged their processes completely uncouple headcount from volume when growth accelerates allowing Canaccord to feel better about its earnings power into a steeper recovery.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for CHRW

Unlock Now

CHRW Should I Buy

CHRW Should I Buy

Should You Buy CH Robinson Worldwide Inc (CHRW) Today? Analysis, Price Targets, and 2026 Outlook.

Technical Analysis

Options Data

Technical Summary

Positive Catalysts

Neutral/Negative Catalysts

Financial Performance

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

People Also Watch